Prevention of Contrast and Radiation Injury During Coronary Angiography and Percutaneous Coronary Intervention

被引：9
作者：
Afshar A.E. [1 ]
Parikh P.B. [1 ]
机构：
[1] Division of Cardiovascular Medicine, Department of Medicine, State University of New York at Stony Brook, Stony Brook, 11794, NY
来源：
Current Treatment Options in Cardiovascular Medicine | 2018年 / 20卷 / 4期
关键词：
Cardiac catheterization; Contrast-induced acute kidney injury; Contrast-induced nephropathy; Radiation injury;
D O I：
10.1007/s11936-018-0621-3
中图分类号：
学科分类号：
摘要：
Purpose of review: In this review, we provide a summary of the recently published literature on various methods of preventing contrast-induced acute kidney injury (CI-AKI) and radiation-related injuries associated with cardiac catheterization and percutaneous coronary intervention (PCI). Recent findings: The overall reported incidence of CI-AKI is declining, primarily due to adaptation of a standardized definition for CI-AKI as well as implementation of pre-procedural protocols to prevent or decrease the risk of CI-AKI. The implementation of increasing awareness and establishing radiation protection culture has been shown to be effective measures in reducing radiation exposure. Summary: Coronary angiography and PCI are valuable diagnostic and therapeutic tools in cardiovascular medicine. Accurate imaging of the coronary arteries in cardiac catheterization is dependent on the use of intravascular injection of iodinated contrast media and fluoroscopic imaging. Patients undergoing diagnostic and interventional cardiac catheterization may be exposed to a substantial amount of contrast media and ionizing radiation. Administration of contrast media is correlated with increased risk of CI-AKI, and exposure to radiation is known to be associated with a spectrum of acute and chronic tissue injuries. © 2018, Springer Science+Business Media, LLC, part of Springer Nature.
引用
收藏
相关论文
共 78 条
  • [11] Weisbord S.D., Chen H., Stone R.A., Kip K.E., Fine M.J., Saul M.I., Palevsky P.M., Associations of increases in serum creatinine with mortality and length of hospital stay after coronary angiography, J Am Soc Nephrol, 17, 10, pp. 2871-2877, (2006)
  • [12] Giacoppo D., Madhavan M.V., Baber U., Warren J., Bansilal S., Witzenbichler B., Dangas G.D., Kirtane A.J., Xu K., Kornowski R., Brener S.J., Genereux P., Stone G.W., Mehran R., Impact of contrast-induced acute kidney injury after percutaneous coronary intervention on short- and long-term outcomes: pooled analysis from the HORIZONS-AMI and ACUITY trials, Circ Cardiovasc Interv, 8, 8, (2015)
  • [13] Rudnick M., Feldman H., Contrast-induced nephropathy: what are the true clinical consequences?, Clin J Am Soc Nephrol, 3, 1, pp. 263-272, (2008)
  • [14] Abe M., Morimoto T., Nakagawa Y., Furukawa Y., Ono K., Kato T., Kadota K., Ando K., Ishii M., Masunaga N., Akao M., Kimura T., Impact of transient or persistent contrast-induced nephropathy on long-term mortality after elective percutaneous coronary intervention, Am J Cardiol, 120, pp. 2146-2153, (2017)
  • [15] Silver S.A., Shah P.M., Chertow G.M., Harel S., Wald R., Harel Z., Risk prediction models for contrast induced nephropathy: systematic review, BMJ, 351, (2015)
  • [16] Mehran R., Aymong E.D., Nikolsky E., Lasic Z., Iakovou I., Fahy M., Mintz G.S., Lansky A.J., Moses J.W., Stone G.W., Leon M.B., Dangas G., A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation, J Am Coll Cardiol, 44, 7, pp. 1393-1399, (2004)
  • [17] Van Praet J.T., De Vriese A.S., Prevention of contrast-induced nephropathy: a critical review, Curr Opin Nephrol Hypertens, 16, 4, pp. 336-347, (2007)
  • [18] Oktay V., Calpar Cirali I., Sinan U.Y., Yildiz A., Ersanli M.K., Impact of continuation of metformin prior to elective coronary angiography on acute contrast nephropathy in patients with normal or mildly impaired renal functions, Anatol J Cardiol, (2017)
  • [19] Davidson C., Stacul F., McCullough P.A., Tumlin J., Adam A., Lameire N., Becker C.R., Contrast medium use, Am J Cardiol, 98, 6A, pp. 42K-58K, (2006)
  • [20] Manske C.L., Sprafka J.M., Strony J.T., Wang Y., Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography, Am J Med, 89, 5, pp. 615-620, (1990)
12345678